RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

raloxifene hydrochloride, Quantity: 60 mg

から入手可能:

MedTAS Pty Ltd

INN（国際名）:

Raloxifene hydrochloride

医薬品形態:

Tablet, film coated

構図:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

投与経路:

Oral

パッケージ内のユニット:

28 tablets

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

製品概要:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2014-01-14